Early Identification of Low-Risk Pulmonary Embolism in Cancer Patients at the Emergency Department An Observational Study Evaluating Prognostic Scores for Safe Early Discharge

What this Trial Is About

Researchers are investigating pulmonary thromboembolism PTE in cancer patients, focusing on those diagnosed either symptomatically or incidentally during cancer follow-up. The study aims to compare several scoring systems used by physicians to identify patients at low risk of serious complications within 30 days of PTE diagnosis. This could help safely discharge low-risk patients early from the emergency department, reducing lengthy hospital stays and their impact on health and psychological well-being. This observational study collects data at emergency department admission, recording information needed to calculate six different risk scores. Patients will receive usual care based on physician judgment, with no experimental treatments involved. Participants will be followed up by phone 30 days after their emergency visit to assess health status and record any major adverse events such as death, respiratory failure, or rehospitalization. The study includes both retrospective data collection and prospective enrollment over approximately three years. Participants will provide informed consent and contribute data during their emergency department visit, which takes about five minutes to collect. Follow-up phone calls last around one minute. Researchers will analyze the performance of the prognostic scores in predicting 30-day outcomes using hospital records and statistical methods. Safety monitoring focuses on identifying patients at low risk who can be discharged early without increased risk of serious complications. Overall participation lasts from initial emergency department contact through a 30-day follow-up period.

Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department